IMTX
Immatics Appoints Alise Reicin to Board of Directors
Wednesday, July 31, 2024 BiopharmaWatch Research 1 min read Key Takeaway: Immatics Appoints Alise Reicin to Board of Directors
Price reaction · baseline $11.88 (2024-07-30 close) · hit after-hours · clean, no other IMTX news in the window
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+20%
120-day peak, hindsight
Typical move
3.9%
average across 7 past catalysts
Lead asset
IMA401
Phase 1 · Refractory Cancer
Full Press Release Details
Immatics Appoints Alise Reicin to Board of Directors.